A042520 Stock Overview
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
HansBiomed Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩13,460.00 |
| 52 Week High | ₩29,700.00 |
| 52 Week Low | ₩11,050.00 |
| Beta | 0.71 |
| 1 Month Change | -8.31% |
| 3 Month Change | 8.46% |
| 1 Year Change | -7.62% |
| 3 Year Change | -11.16% |
| 5 Year Change | -51.50% |
| Change since IPO | 113.31% |
Recent News & Updates
Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Feb 29
HansBiomed Corporation (KOSDAQ:042520) Shares Fly 25% But Investors Aren't Buying For Growth
Feb 29Recent updates
Is HansBiomed (KOSDAQ:042520) A Risky Investment?
Feb 29HansBiomed Corporation (KOSDAQ:042520) Shares Fly 25% But Investors Aren't Buying For Growth
Feb 29Are Dividend Investors Making A Mistake With HansBiomed Corporation (KOSDAQ:042520)?
Apr 10Does HansBiomed (KOSDAQ:042520) Have A Healthy Balance Sheet?
Mar 06HansBiomed's(KOSDAQ:042520) Share Price Is Down 63% Over The Past Three Years.
Jan 30Are HansBiomed's (KOSDAQ:042520) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Dec 08
Declining Stock and Decent Financials: Is The Market Wrong About HansBiomed Corporation (KOSDAQ:042520)?
Nov 20Shareholder Returns
| A042520 | KR Biotechs | KR Market | |
|---|---|---|---|
| 7D | -4.9% | -0.6% | -2.4% |
| 1Y | -7.6% | 2.4% | 1.9% |
Return vs Industry: A042520 underperformed the KR Biotechs industry which returned 2.4% over the past year.
Return vs Market: A042520 underperformed the KR Market which returned 1.9% over the past year.
Price Volatility
| A042520 volatility | |
|---|---|
| A042520 Average Weekly Movement | 8.1% |
| Biotechs Industry Average Movement | 8.2% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A042520 has not had significant price volatility in the past 3 months.
Volatility Over Time: A042520's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 254 | Guen Young Kim | www.hansbiomed.com |
HansBiomed Corporation, together with its subsidiaries, engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies. The company provides ExFuse, a demineralized bone matrix with cancellous bone gel/putty; BellaFuse, a demineralized bone matrix; Genesis, a cancellous sponge block/filler; Pedi-Stick, a demineralized cortical bone stick; SureChip, a cancellous bone chip; OsteoGrow, a demineralized bone matrix inserter; BellaCell HD, an allograft dermal product that transplanted in a patient whose skin has been lost due to breast cancer; and SureDerm, an acellular dermal matrix. It also offers BELLAGEL, a breast prosthesis, internal, and gel-filled solution; MINT Lift, a PDO thread; EZ-Tcon solution; Lion HT/HN, a hair transplanter body/needle; and Scar Clinic, a scar management solution.
HansBiomed Corporation Fundamentals Summary
| A042520 fundamental statistics | |
|---|---|
| Market cap | ₩174.80b |
| Earnings (TTM) | -₩20.48b |
| Revenue (TTM) | ₩78.32b |
2.2x
P/S Ratio-8.5x
P/E RatioIs A042520 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A042520 income statement (TTM) | |
|---|---|
| Revenue | ₩78.32b |
| Cost of Revenue | ₩31.87b |
| Gross Profit | ₩46.46b |
| Other Expenses | ₩66.94b |
| Earnings | -₩20.48b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.58k |
| Gross Margin | 59.31% |
| Net Profit Margin | -26.15% |
| Debt/Equity Ratio | 37.3% |
How did A042520 perform over the long term?
See historical performance and comparison